Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON REQUEST

IGF-1 LR3 vs GLP-2/Tirz: What Is the Difference?

A fragile folded protein against a long engineered chain that behaves like soap. Both need care, neither in the same way.

Shared research areas:Metabolic

Overview

What GLP-2/Tirz is

IGF-1 LR3 is a folded protein of eighty-three amino acids, a modified growth signal engineered to avoid capture by carrier proteins.

What IGF-1 LR3 is

GLP-2/Tirz is an engineered molecule acting on two incretin receptors — the gut-hormone system involved in blood sugar regulation — built on a GIP backbone.

The difference, without the jargon

Different systems entirely: growth signalling for one, gut hormones for the other. What makes the pairing useful is that both are fragile and neither is fragile in the way people expect. IGF-1 LR3 is fragile because it has a folded shape that can come undone; it will not dissolve in plain water, cannot be thawed repeatedly, and gives no visible warning when ruined. GLP-2/Tirz is fragile because its long fatty chain makes it amphiphilic — soap-like — so it gathers at the boundary between liquid and air and comes apart there. Shake it and the foam you see is the damage. Neither should be frozen once dissolved, and neither should be agitated, though for different underlying reasons.

Common questions

What is the difference between IGF-1 LR3 and GLP-2/Tirz?

IGF-1 LR3 is a folded protein studied as a growth signal. GLP-2/Tirz is an engineered molecule acting on gut-hormone receptors involved in blood sugar regulation. Unrelated systems and different molecular classes.

Why does GLP-2/Tirz foam?

It carries a long fatty chain that makes one end water-loving and the other water-repelling, like soap. Such molecules gather where liquid meets air and unfold there, so foam represents damaged material rather than harmless bubbles.

Can either be frozen after dissolving?

Neither should be. Ice formation damages both, and in both cases the damage does not reverse when the vial warms up. Single-use portions are the standard approach for IGF-1 LR3 in particular.

Technical reference below

ClassLipidated dual receptor agonist (GIP / GLP-1), 39-residue chainRecombinant 83-residue protein analogue of IGF-1
Molecular weight4813.5 g/molNot specified
CAS numberNot assigned / not specifiedNot assigned / not specified
Purity spec≥99%≥99%
Research areasMetabolicHormonal & Endocrine, Metabolic, Musculoskeletal
Primary diluentBacteriostatic water (0.9% benzyl alcohol)Dilute acetic acid (0.1 M) or 10 mM HCl — required for initial dissolution
Working windowCommonly worked with for 4–6 weeks at 2–8 °C.Short: commonly worked with within 1–2 weeks at 2–8 °C, or frozen in single-use aliquots.
Lead degradation routeInterfacial aggregation from agitation or freezing — the dominant practical route.Denaturation and aggregation — the dominant failure mode, and one that has no equivalent in short unstructured peptides.
Freeze–thawDo not freeze reconstituted solution. Interfacial aggregation during freezing is the characteristic failure mode and is irreversible.Single-use aliquots are the standard practice, and here it genuinely matters. IGF-1 LR3 has tertiary structure to lose — unlike the unstructured short peptides in this catalogue, it can denature, and denaturation is not reversible on rewarming.
Light sensitivityNo specific light requirement beyond normal practice.No specific light requirement beyond normal practice.

How they actually differ

Comparing the two: GLP-2/Tirz is lipidated dual receptor agonist (gip / glp-1), 39-residue chain, while IGF-1 LR3 is recombinant 83-residue protein analogue of igf-1 — different molecular classes with different handling consequences; they call for different primary diluents (bacteriostatic water (0.9% benzyl alcohol) versus dilute acetic acid (0.1 m) or 10 mm hcl — required for initial dissolution); their leading degradation routes differ (interfacial aggregation from agitation or freezing for GLP-2/Tirz, denaturation and aggregation for IGF-1 LR3), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.

GLP-2/Tirz — origin

GLP-2/Tirz is built on a GIP-based backbone rather than a GLP-1 one — an important and often-missed design detail. It was engineered from the GIP sequence and modified to acquire GLP-1 receptor activity, with a C20 fatty diacid attached via a linker for albumin binding. The term "twincretin" describes the dual incretin activity.

IGF-1 LR3 — origin

IGF-1 LR3 is an engineered analogue carrying two changes to native IGF-1: an arginine substitution at position 3 and a 13-residue N-terminal extension. The Arg3 substitution is the functional one — it drastically reduces binding to IGF binding proteins, which normally sequester the great majority of circulating IGF-1. The result is a molecule that stays free rather than bound.

GLP-2/Tirz research themes

Dual incretin engagement

Simultaneous GIP and GLP-1 receptor activity from a GIP-derived backbone.

Insulin secretion and glucagon suppression

Core metabolic research endpoints for the incretin class.

Gastric emptying

A well-characterised GLP-1 pathway effect studied in metabolic models.

GIP receptor pharmacology

Whether GIP agonism or antagonism is the productive direction remains an active research debate.

IGF-1 LR3 research themes

IGFBP evasion

The Arg3 substitution reduces binding-protein affinity, which is the entire design rationale.

Cell proliferation

Widely used in cell-culture research as a growth-factor supplement.

Satellite cell activation

Studied in muscle-biology research models.

PI3K/Akt signalling

The canonical downstream pathway examined in IGF-1 receptor research.

GLP-2/Tirz handling

  • Swirl, never shake or vortex.
  • Add diluent down the vial wall and give the cake time — several minutes of slow dissolution is normal, not a defect.
  • Store upright and refrigerated; do not freeze once reconstituted.

IGF-1 LR3 handling

  • Dissolve in dilute acetic acid or dilute HCl FIRST; do not attempt direct dissolution in water or PBS.
  • Add carrier protein (e.g. 0.1% BSA) for storage of dilute solutions to prevent adsorptive loss.
  • Prepare single-use aliquots — freeze–thaw denaturation is irreversible.
  • Do not vortex; agitation denatures folded proteins at the air–liquid interface.

Both third-party tested

Every Popular Peptides batch of GLP-2/Tirz and IGF-1 LR3 is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.

GLP-2/Tirz reference

IGF-1 LR3 reference

Related comparisons

GLP-2/Tirz and IGF-1 LR3 are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.